Johnson & Johnson poaches Sanofi’s top R&D executive

Johnson & Johnson announced Monday afternoon that John Reed, previously the head of research and development at Sanofi, would take over pharmaceuticals R&D at the country’s largest health conglomerate.

Sanofi, where Reed had worked since 2018, announced earlier Monday that he was departing to pursue a new opportunity.

“I am deeply honored and extremely excited to join Johnson & Johnson,” Reed said in a prepared statement. “I share the company’s commitment to innovation to conquer disease and improve human health, and I look forward to applying my passion for science, experience in drug discovery and development and commitment to helping patients in leading the talented pharmaceutical R&D team.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In